Genetics of Women With Lobular Carcinoma in Situ of the Breast

Study Overview
=================
Brief Summary
-----------------
RATIONALE: Gathering information about genetic changes in patients with lobular carcinoma in situ of the breast may help doctors learn more about the disease and find better methods of treatment. PURPOSE: This clinical trial is studying the genetics of women with lobular carcinoma in situ of the breast.

Detailed Description
-----------------
OBJECTIVES: Primary Identify inherited variation that predisposes women to develop lobular carcinoma in situ (LCIS) of the breast. Identify the frequency of these variants and determine the effect they have on tumor risk. Determine how worthwhile it would be to test for these variants in the clinical setting so that those at higher risk could be identified, counseled, and screened. Secondary Analysis of genetic changes within LCIS with the aim of identifying cases of LCIS which may progress to invasive cancer. OUTLINE: Patients and control participants undergo blood collection. DNA is extracted from blood samples and used to genotype at selected polymorphisms, compare allele frequencies (used to associate alleles with disease) using a genome-wide single nucleotide polymorphism (SNP) screen. Archival tumor samples (if available) from patients are used for DNA-, RNA-, or protein-based analyses. All participants complete a questionnaire about family history, a brief medical history, and provide epidemiological data to a genetic counselor. Participants identified to be at risk for known hereditary predisposition to cancer will be referred to a clinical genetics service. Individual results of this study are not disclosed to participants. Peer Reviewed and Funded or Endorsed by Cancer Research UK. PROJECTED ACCRUAL: A total of 2,000 participants (1,000 patients and 1,000 matched controls) will be accrued for this study.

Official Title
-----------------
GLACIER: A Study to Investigate the Genetics of LobulAr Carcinoma In Situ in EuRope

Conditions
-----------------
Breast Cancer

Intervention / Treatment
-----------------
* Genetic: gene expression analysis
* Genetic: molecular diagnostic method
* Genetic: polymorphism analysis
* Genetic: protein expression analysis
* Other: medical chart review
* Other: questionnaire administration


Participation Criteria
=================
Eligibility Criteria
-----------------
DISEASE CHARACTERISTICS: Meets 1 of the following criteria: Current or prior diagnosis of lobular carcinoma in situ (LCIS) of the breast, including any of the following cases: Pure LCIS LCIS with subsequent development of invasive breast cancer of any morphological subtype LCIS presenting as an incidental finding together with invasive breast cancer of any morphological subtype Control participant matched for age and ethnicity to each LCIS patient Not affected by LCIS No history of ductal carcinoma in situ of the breast No breast cancer No relative (up to 2nd degree) who has been affected by breast cancer Male or female PATIENT CHARACTERISTICS: Not specified PRIOR CONCURRENT THERAPY: Not specified

Ages Eligible for Study
-----------------
Maximum Age: 60 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Genetic: gene expression analysis|nan|
|Genetic: molecular diagnostic method|nan|
|Genetic: polymorphism analysis|nan|
|Genetic: protein expression analysis|nan|
|Other: medical chart review|nan|
|Other: questionnaire administration|nan|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Inherited variation predisposing development of lobular carcinoma in situ (LCIS) of the breast in women |  |  | 
| Frequency and effect of variants on tumor risk |  |  | 
| Clinical setting variant test value in identifying, counseling and screening those women at higher risk |  |  | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| LCIS genetic changes which may progress to invasive cancer |  |  | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
invasive lobular breast carcinoma with predominant in situ component, invasive lobular breast carcinoma, lobular breast carcinoma in situ